PATENT CLAIM ANALYSIS

Application Number: 15771195
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "468000"]

Abstract:
Provided are methods of treating various forms of hearing loss caused by aberrant calcium fluxes in auditory cells. The methods encompass the administration of agents which prevent abnormal calcium fluxes, stabilize SERCA2b activity, or prevent ER UPR apoptotic responses. The methods include therapeutic treatments of subjects suffering from hearing loss as well as preventative treatments which protect auditory cells from cell death, for example as caused by exposure to loud noise.

Claim (Index 53):
The method of  claim 52 , wherein\n the treatment comprises the administration of vanadate, eosin, or caloxin peptides.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 91.0
- Lexical Diversity: 1.45283
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13380143', '10345731', '15796522', '15230257', '13233907']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7329666855167936
- 35 USC 102 Novelty (BERT): 0.4936808717284159
- Combined Prediction Score: 0.7090381041379558
- Mean Citation Score: 148.794468
- Max Citation Score: 159.96497
- Similarity Product: 99.99006270763756

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test